Why the study?
Does long-term dicumarol therapy prevent recurrent coronary artery thrombosis in patients with prior myocardial infarction?
Does long-term dicumarol therapy prevent recurrent coronary artery thrombosis in patients with prior myocardial infarction?
Long-term dicumarol therapy is feasible for ambulatory patients and may prevent recurrent coronary thrombosis after myocardial infarction.
Answers are grounded in this paper and cite their sources.
Recurrent thrombosis uncommon in these dicumarol-treated fatal cases; leaves open whether long-term anticoagulation prevents post-MI events.
Seventy-eight patients were given long-term dicumarol therapy after one or more attacks of myocardial infarction to see whether recurrent attacks could be warded off. Encouraging results ensued over periods up to five years. Protocols of 12 fatal cases are given, only 4 of whom had recurrent acute coronary thrombosis. Hemorrhagic complications met with are analyzed. Ambulatory treatment is shown to be feasible if patients are painstakingly followed.
No takes yet. Share an insight, caveat, or question.
Nichol et al. (1950) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: